Nomura Holdings, Inc.

NYSE:NMR

Financial - Capital Markets

Financial Services
$9.23 -1.32%

-$0.12 today

Market cap
$27.29B
Beta
0.61
P/E (TTM)
0.3
EPS (TTM)
$4,986.67
Dividend yield
3.55%
52W Low $6.02High $9.58

Volume 3.51M

Average 1.75M

NMR Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

Nomura Holdings, Inc.NYSE: NMR

Capital Expenditures · Q4 FY2026 · quarter ended Mar 2026

Capital expenditures outflow grows to ¥0

Q4 FY2026 capital expenditures was ¥0, compared with ¥0 a year earlier. Trailing-twelve-month capital expenditures was ¥0. Over 3 fiscal years it compounded at +27.4% a year.

Context

  • Capital expenditures amounted to 7.4% of revenue in FY2026, up 3.2 pp from a year earlier.
  • Capital expenditures grew in size in 2 of the last 3 fiscal years.
  • FY2026 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly capital expenditures holds near ¥0 or moves back toward the trailing-twelve-month quarterly average of ¥0.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
¥0— QoQ
Last fiscal yearMar 2026
-¥353.82B+86.2% YoY
LTMMar 2026
¥0— YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year+86.2%——
3-year CAGR+27.4%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

JPY · from the cash flow

Latest · FY2026
(353.82B) JPY
Year-over-year change
-86.2%

Capital Expenditures vs competitors

How NMR compares with its peers on the latest reported figures

  • Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
  • Capital expenditures amounts to 0.0% of revenue for NMR, versus a peer median of 0.7%.
NMR Competitors
Capital Expenditures for NMR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GSThe Goldman Sachs Group, Inc.LTM Jun 2026$2.16B USD+6.4%-18.0%1.8%
UBSUBS Group AGLTM Mar 2026$1.67B USD-22.6%+4.5%2.2%
MSMorgan StanleyLTM Sep 2026$616M USD+120.1%-2.0%0.5%
JEFJefferies Financial Group Inc.LTM Aug 2026$218.25M USD-1.4%-2.6%1.8%
EVREvercore Inc.LTM Jun 2026$42.13M USD-37.0%+47.2%0.9%
SFStifel Financial Corp.LTM Jun 2026$30.68M USD-50.2%-9.0%0.5%
LAZLazard LtdLTM Sep 2026$9.21M USD-38.1%-13.6%0.3%
OPYOppenheimer Holdings Inc.LTM Mar 2026$3.51M USD-46.6%-31.7%0.2%
NMRNomura Holdings, Inc.LTM Mar 2026¥0 JPY—+27.4%0.0%
Peer median (excluding NMR) —-29.8%-5.8%0.7%

Competitors are the stored peer set for NMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

JPY
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Net Income146.53B91.68B177.22B347.26B374.38B
Depreciation & Amortization59.52B61.42B61.34B61.65B68.27B
Deferred Income Tax3.11B6.14B(312M)11.56B0
Stock-Based Compensation27.94B35.22B51.51B38.58B0
Change in Working Capital(874.99B)(453.66B)(116.12B)(1.11T)(1.23T)
Accounts Receivables0000(653.33B)
Inventory0000(2.86T)
Accounts Payables(247.98B)(139.42B)709.84B01.81T
Other Working Capital(627.01B)(314.25B)(825.95B)(1.11T)474.21B
Other Non-Cash Items(224.95B)(435.61B)(41.01B)(25.47B)(59.57B)
Operating Cash Flow(862.83B)(694.82B)132.64B(678.61B)(842.96B)
Capital Expenditures(111.33B)(171.17B)(145.78B)(189.97B)(353.82B)
Acquisitions (Net)016.95B(457M)8.14B(275B)
Purchases of Investments(115.21B)(75.5B)(156.93B)(322.45B)(8.9T)
Sales of Investments205.53B301.07B177.09B154.39B7.95T
Other Investing Activities(572.17B)(304.58B)(761.85B)(498.76B)(151.66B)
Investing Cash Flow(593.18B)(233.23B)(887.94B)(848.65B)(1.5T)
Debt Repayment861.78B1.02T1.03T1.1T1.55T
Common Stock Issued11M4M953M1.41B422M
Common Stock Repurchased(39.65B)(24.73B)(61.03B)(59.01B)(101.5B)
Dividends Paid(70.71B)(57.26B)(60.16B)(112.54B)(179.74B)
Other Financing Activities361.29B341.9B116.79B748.75B828.23B
Financing Cash Flow1.11T1.28T1.01T1.68T2.1T
Effect of Forex Changes149.69B148.55B220.62B(26.02B)139.31B
Net Change in Cash(193.6B)504.44B478.17B126.42B(106.72B)
Free Cash Flow(974.16B)(865.99B)(13.14B)(868.58B)(1.2T)

Nomura Holdings, Inc.

NYSE:NMR

Intrinsic Alpha fair value

Locked

Current Price

$9.23

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.